Cytophage Technologies Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Steven Theriault
Chief executive officer
CA$350.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | less than a year |
| CEO ownership | 9.3% |
| Management average tenure | no data |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -CA$8m |
| Dec 31 2023 | CA$350k | CA$350k | -CA$5m |
| Dec 31 2022 | CA$350k | CA$350k | -CA$4m |
Compensation vs Market: Steven's total compensation ($USD256.32K) is above average for companies of similar size in the Canadian market ($USD175.69K).
Compensation vs Earnings: Steven's compensation has been consistent with company performance over the past year.
CEO
Steven Theriault
less than a year
Tenure
CA$350,000
Compensation
Dr. Steven Theriault, B.Sc., M.Sc., Ph D., is Chief Executive Officer, Chief Science Officer & Director of Cuspis Capital III Ltd. (formerly known as Cytophage Technologies Inc.) Dr. Steven Theriault is a...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, Chief Science Officer & Director | less than a year | CA$350.00k | 9.3% CA$ 1.9m | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | 1.12% CA$ 230.8k | |
| Director | 4.8yrs | no data | 0.90% CA$ 185.8k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | 0.19% CA$ 38.5k | |
| Independent Director | less than a year | no data | 0.074% CA$ 15.4k |
0.3yrs
Average Tenure
59.5yo
Average Age
Experienced Board: CYTO's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.